appliedclinicaltrialsonline7h
HELIOS-B Trial Confirms Amvuttra Reduces Mortality, Cardiovascular Events in ATTR-CM Patients
Phase III HELIOS-B trial found that Amvuttra (vutrisiran) also preserved functional capacity and quality of life in patients ...
appliedclinicaltrialsonline8h
Reaching Diverse Patient Populations With Personalized Treatment Methods
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical ...